메뉴 건너뛰기




Volumn 68, Issue 1, 2014, Pages 59-69

Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL)

Author keywords

2' O Fucosyllactose; 2'FL; Gavage; Human milk oligosaccharide; Infant formula; Juvenile rats; Mutagenicity; Safety; Sub chronic toxicity

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE; OLIGOSACCHARIDE 2' O FUCOSYLLACTOSE; UNCLASSIFIED DRUG;

EID: 84889667807     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.11.005     Document Type: Article
Times cited : (60)

References (32)
  • 1
    • 79952201221 scopus 로고    scopus 로고
    • Chapter 2: preclinical evaluation of juvenile toxicity
    • Barrow P., Barbellion S., Stadler J. Chapter 2: preclinical evaluation of juvenile toxicity. Methods Mol. Biol. 2011, 691:17-35.
    • (2011) Methods Mol. Biol. , vol.691 , pp. 17-35
    • Barrow, P.1    Barbellion, S.2    Stadler, J.3
  • 2
    • 84864465909 scopus 로고    scopus 로고
    • Human milk oligosaccharides: every baby needs a sugar mama
    • Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012, 22(9):1147-1162.
    • (2012) Glycobiology , vol.22 , Issue.9 , pp. 1147-1162
    • Bode, L.1
  • 3
    • 0343484259 scopus 로고    scopus 로고
    • Evaluation of safety of inulin and oligofructose as dietary fiber
    • Carrabin I.G., Flamm G. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul. Toxicol. Pharmacol. 1999, 30:268-282.
    • (1999) Regul. Toxicol. Pharmacol. , vol.30 , pp. 268-282
    • Carrabin, I.G.1    Flamm, G.2
  • 4
    • 0031571579 scopus 로고    scopus 로고
    • Milk oligosaccharide profiles by reversed-phase HPLC of their perbenzoylated derivatives
    • Chaturvedi P., Warren C.D., Ruiz-Palacios G.M., et al. Milk oligosaccharide profiles by reversed-phase HPLC of their perbenzoylated derivatives. Anal. Biochem. 1997, 251:89-97.
    • (1997) Anal. Biochem. , vol.251 , pp. 89-97
    • Chaturvedi, P.1    Warren, C.D.2    Ruiz-Palacios, G.M.3
  • 5
    • 0034917101 scopus 로고    scopus 로고
    • Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation
    • Chaturvedi P., Warren C.D., Altaye M., et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001, 11(5):365-372.
    • (2001) Glycobiology , vol.11 , Issue.5 , pp. 365-372
    • Chaturvedi, P.1    Warren, C.D.2    Altaye, M.3
  • 6
    • 0027518583 scopus 로고
    • Changes in carbohydrate composition in human milk over 4months of lactation
    • Coppa G.V., Gabrielli O., Pierani P., et al. Changes in carbohydrate composition in human milk over 4months of lactation. Pediatrics 1993, 91:637-641.
    • (1993) Pediatrics , vol.91 , pp. 637-641
    • Coppa, G.V.1    Gabrielli, O.2    Pierani, P.3
  • 7
    • 0032831862 scopus 로고    scopus 로고
    • Oligosaccharides in human milk during different phases of lactation
    • Coppa G.V., Pierani P., Carloni I., et al. Oligosaccharides in human milk during different phases of lactation. Acta Paediatr. Suppl. 1999, 430:89-94.
    • (1999) Acta Paediatr. Suppl. , vol.430 , pp. 89-94
    • Coppa, G.V.1    Pierani, P.2    Carloni, I.3
  • 8
    • 84885217503 scopus 로고    scopus 로고
    • Pre-clinical safety assessment of the synthetic human milk, nature-identical, oligosaccharide Lacto-N-neotetraose (LNnT)
    • Coulet M., Phothirath P., Constable A., et al. Pre-clinical safety assessment of the synthetic human milk, nature-identical, oligosaccharide Lacto-N-neotetraose (LNnT). Food Chem. Toxicol. 2013, 62:528-537.
    • (2013) Food Chem. Toxicol. , vol.62 , pp. 528-537
    • Coulet, M.1    Phothirath, P.2    Constable, A.3
  • 9
    • 84889683064 scopus 로고    scopus 로고
    • EMEA, Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. Ref. EMEA/CHMP/SWP/169215/2005.
    • EMEA, 2008. Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. Ref. EMEA/CHMP/SWP/169215/2005.
    • (2008)
  • 10
    • 0034091407 scopus 로고    scopus 로고
    • Variability of human milk neutral oligosaccharides in a diverse population
    • Erney R.M., Malone W.T., Skelding M.B., et al. Variability of human milk neutral oligosaccharides in a diverse population. J. Pediatr. Gastroenterol. Nutr. 2000, 30(2):181-192.
    • (2000) J. Pediatr. Gastroenterol. Nutr. , vol.30 , Issue.2 , pp. 181-192
    • Erney, R.M.1    Malone, W.T.2    Skelding, M.B.3
  • 11
    • 35148891167 scopus 로고    scopus 로고
    • Efforts to emulate human milk oligo-saccharides
    • Espinosa R.M., Tamez M., Prieto P. Efforts to emulate human milk oligo-saccharides. Br. J. Nutr. 2007, 8(Suppl. 1):S74-S79.
    • (2007) Br. J. Nutr. , vol.8 , Issue.SUPPL. 1
    • Espinosa, R.M.1    Tamez, M.2    Prieto, P.3
  • 12
    • 84878216058 scopus 로고    scopus 로고
    • Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment
    • Everds N.E., Snyder P.W., Bailey K.L., et al. Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol. Pathol. 2013, 41(4):560-614.
    • (2013) Toxicol. Pathol. , vol.41 , Issue.4 , pp. 560-614
    • Everds, N.E.1    Snyder, P.W.2    Bailey, K.L.3
  • 13
    • 84867731329 scopus 로고    scopus 로고
    • Biotechnological production of human milk oligosaccharides
    • Han N.S., Kim T.J., Park Y.C., et al. Biotechnological production of human milk oligosaccharides. Biotechnol. Adv. 2012, 30(6):1268-1278.
    • (2012) Biotechnol. Adv. , vol.30 , Issue.6 , pp. 1268-1278
    • Han, N.S.1    Kim, T.J.2    Park, Y.C.3
  • 14
    • 83055184171 scopus 로고    scopus 로고
    • The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion
    • Hickey R.M. The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion. Int. Dairy J. 2012, 22:141-146.
    • (2012) Int. Dairy J. , vol.22 , pp. 141-146
    • Hickey, R.M.1
  • 15
    • 70449378043 scopus 로고    scopus 로고
    • Safety of a novel galacto-oligosaccharide: genotoxicity and repeated oral dose studies
    • Kobayashi T., Yasutake N., Uchida K., et al. Safety of a novel galacto-oligosaccharide: genotoxicity and repeated oral dose studies. Hum. Exp. Toxicol. 2009, 28(10):619-630.
    • (2009) Hum. Exp. Toxicol. , vol.28 , Issue.10 , pp. 619-630
    • Kobayashi, T.1    Yasutake, N.2    Uchida, K.3
  • 16
    • 0033826695 scopus 로고    scopus 로고
    • Oligosaccharides in human milk: structural, functional, and metabolic aspects
    • Kunz C., Rudloff S., Baier W., et al. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 2000, 20:699-722.
    • (2000) Annu. Rev. Nutr. , vol.20 , pp. 699-722
    • Kunz, C.1    Rudloff, S.2    Baier, W.3
  • 18
    • 80052661466 scopus 로고    scopus 로고
    • Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophobic interaction chromatography
    • Marino K., Lane J.A., Abrahams J.L., et al. Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophobic interaction chromatography. Glycobiology 2011, 21(10):1317-1330.
    • (2011) Glycobiology , vol.21 , Issue.10 , pp. 1317-1330
    • Marino, K.1    Lane, J.A.2    Abrahams, J.L.3
  • 19
    • 4444241042 scopus 로고    scopus 로고
    • Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants
    • Morrow A.L., Ruiz-Palacios G.M., Altaye M., et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J. Pediatr. 2004, 145:297-303.
    • (2004) J. Pediatr. , vol.145 , pp. 297-303
    • Morrow, A.L.1    Ruiz-Palacios, G.M.2    Altaye, M.3
  • 20
    • 84889685074 scopus 로고    scopus 로고
    • OECD, OECD guidelines for testing of chemicals Nos. 471 and 476 Genetic Toxicology: Bacterial reverse mutation test and in vitro mammalian cell gene mutation test, respectively.
    • OECD, 1997. OECD guidelines for testing of chemicals Nos. 471 and 476 Genetic Toxicology: Bacterial reverse mutation test and in vitro mammalian cell gene mutation test, respectively.
    • (1997)
  • 21
    • 84889638555 scopus 로고    scopus 로고
    • OECD, OECD GUIDELINE for testing of chemicals No. 408. Repeated dose 90-day oral toxicity in rodents.
    • OECD, 1998. OECD GUIDELINE for testing of chemicals No. 408. Repeated dose 90-day oral toxicity in rodents.
    • (1998)
  • 22
    • 0036019911 scopus 로고    scopus 로고
    • A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria
    • Priem B., Gilbert M., Wakarchuk W.W., et al. A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. Glycobiology 2002, 12(4):235-240.
    • (2002) Glycobiology , vol.12 , Issue.4 , pp. 235-240
    • Priem, B.1    Gilbert, M.2    Wakarchuk, W.W.3
  • 23
    • 0013238319 scopus 로고    scopus 로고
    • Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyl oligosaccharides of human milk inhibit its binding and infection
    • Ruiz-Palacios G.M., Cervantes L.E., Ramos P., et al. Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyl oligosaccharides of human milk inhibit its binding and infection. J. Biol. Chem. 2003, 278:14112-14120.
    • (2003) J. Biol. Chem. , vol.278 , pp. 14112-14120
    • Ruiz-Palacios, G.M.1    Cervantes, L.E.2    Ramos, P.3
  • 24
    • 78149471642 scopus 로고    scopus 로고
    • Variation of human milk oligosaccharides in relation to milk groups and lactational periods
    • Thurl S., Munzert M., Henker J. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br. J. Nutr. 2010, 104:1261-1271.
    • (2010) Br. J. Nutr. , vol.104 , pp. 1261-1271
    • Thurl, S.1    Munzert, M.2    Henker, J.3
  • 25
    • 84866787871 scopus 로고    scopus 로고
    • The predominance of type I oligosaccharides is a feature specific to human breast milk
    • Urashima T., Asakuma S., Leo F., et al. The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv. Nutr. 2012, 3:473S-482S.
    • (2012) Adv. Nutr. , vol.3
    • Urashima, T.1    Asakuma, S.2    Leo, F.3
  • 26
    • 84876397856 scopus 로고    scopus 로고
    • Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals
    • Urashima T., Taufik E., Fukuda K., et al. Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci. Biotechnol. Biochem. 2013, 77(3):455-466.
    • (2013) Biosci. Biotechnol. Biochem. , vol.77 , Issue.3 , pp. 455-466
    • Urashima, T.1    Taufik, E.2    Fukuda, K.3
  • 27
    • 84889690594 scopus 로고    scopus 로고
    • US FDA, Guidance for industry: nonclinical safety evaluation of pediatric drug products, February 2006.
    • US FDA, 2006. Guidance for industry: nonclinical safety evaluation of pediatric drug products, February 2006.
    • (2006)
  • 28
    • 0036085947 scopus 로고    scopus 로고
    • Oligosaccharides in infant formula
    • Vandenplas Y. Oligosaccharides in infant formula. Br. J. Nutr. 2002, 87(Suppl. 2):S293-S296.
    • (2002) Br. J. Nutr. , vol.87 , Issue.SUPPL. 2
    • Vandenplas, Y.1
  • 29
    • 79959242589 scopus 로고    scopus 로고
    • Physiological and bifidogenic effects of prebiotic supplements in infant formulae
    • Veereman-Wauters G., Staelens S., Van de Broek H., et al. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J. Pediatr. Gastroenterol. Nutr. 2011, 52(6):763-771.
    • (2011) J. Pediatr. Gastroenterol. Nutr. , vol.52 , Issue.6 , pp. 763-771
    • Veereman-Wauters, G.1    Staelens, S.2    Van de Broek, H.3
  • 30
    • 0025003004 scopus 로고
    • Variations in oligosaccharides and lactose in human milk during the first week of lactation
    • Viverge D., Grimmonprez L., Cassanas G. Variations in oligosaccharides and lactose in human milk during the first week of lactation. J. Pediatr. Gastroenterol. Nutr. 1990, 11:361-364.
    • (1990) J. Pediatr. Gastroenterol. Nutr. , vol.11 , pp. 361-364
    • Viverge, D.1    Grimmonprez, L.2    Cassanas, G.3
  • 31
    • 84884591440 scopus 로고    scopus 로고
    • Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines
    • Weichert, S., Jennewein, S., Hüfner, E., et al., 2013. Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr. Res. 33, 831-838.
    • (2013) Nutr. Res. , vol.33 , pp. 831-838
    • Weichert, S.1    Jennewein, S.2    Hüfner, E.3
  • 32
    • 84889684970 scopus 로고
    • A survey of physical growth, nutritional intake, fecal properties and morbidity of infants as related to feeding methods
    • Yamamota Y., Yonekubo A. A survey of physical growth, nutritional intake, fecal properties and morbidity of infants as related to feeding methods. Jpn. Infant 1993.
    • (1993) Jpn. Infant
    • Yamamota, Y.1    Yonekubo, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.